cyc 202 has been researched along with ag-1296 in 2 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (ag-1296) | Trials (ag-1296) | Recent Studies (post-2010) (ag-1296) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 121 | 2 | 36 |
| Protein | Taxonomy | cyc 202 (IC50) | ag-1296 (IC50) |
|---|---|---|---|
| Platelet-derived growth factor receptor beta | Mus musculus (house mouse) | 0.8 | |
| Platelet-derived growth factor receptor alpha | Mus musculus (house mouse) | 0.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Colanesi, S; Ishizaki, H; Kelsh, RN; Liu, D; Lundegaard, PR; North, TE; Patton, EE; Taylor, KL; Temperley, ND | 1 |
2 other study(ies) available for cyc 202 and ag-1296
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Small molecule screening identifies targetable zebrafish pigmentation pathways.
Topics: Animals; Cell Count; Chromatophores; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Embryo, Nonmammalian; Heterocyclic Compounds, 3-Ring; Melanocytes; Metabolic Networks and Pathways; Phenotype; Pigmentation; Purines; Pyrimidinones; Roscovitine; Small Molecule Libraries; Tyrphostins; Zebrafish | 2012 |